Live
- DEO suspends teacher accused of sexual assault
- PM ‘cursing’ Congress out of despair: Maharashtra Cong Chief
- Applications are invited for Junior Colleges Scheme District Scheduled Castes Development Officer Ramlal
- A nomination was filed on the second day for the Nagar Kurnool parliamentary seat
- SP Gaikwad inspected the Telangana Amarnath Saleswaram Jatara yatra arrangements
- Rahul Gandhi's decision to contest from Wayanad shows 'lack of confidence': BJP President Nadda
- IPL 2024: Delhi bowlers will go after all of SRH’s top-order batters, says head coach Ricky Ponting
- At Amroha rally, PM Modi sends out ‘meaningful’ message for Muslims and Hindus
- Tripura records highest 79.83 pc voter turnout in Northeast
- The government has to clear the confusion
Wockhardt hit by fresh UK ban
Highlights
Wockhardt Hit By Fresh UK Ban. Britain's drug authorities have revoked their approval for one of Wockhardt's key plants -- a fresh regulatory rebuke that sent shares in the Indian drugmaker tumbling and underscoring the long road it faces in restoring its reputation.
MUMBAI: Britain's drug authorities have revoked their approval for one of Wockhardt's key plants -- a fresh regulatory rebuke that sent shares in the Indian drugmaker tumbling and underscoring the long road it faces in restoring its reputation.
The withdrawal of the good manufacturing practice certificate means the generic drugmaker's Chikalthana plant — one of its main revenue generators — will no longer be able to supply many products to Britain.
The admonition comes on top of a ban on drug shipments to the US and Britain from a separate Wockhardt factory after hygiene and other compliance deficiencies were found. India's pharmaceutical industry has come under the spotlight for a string of compliance lapses over the past three years, that have resulted in more scrutiny as well as a record fine for Wockhardt rival Ranbaxy Laboratories.
Next Story
ADVERTISEMENT
